Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Attenuated mannheimia haemolytica vaccines and methods of making and use

Attenuated mannheimia haemolytica vaccines and methods of making and use

US Patent 9370561 · Granted Jun 21, 2016

Estimated economic value: $145,575,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enzyme-linked immunosorbent assay (ELISA) for the detection of anti-mycoplasma h2021
Enzyme-linked immunosorbent assay (ELISA) for the detection of anti-mycoplasma h2021
Streptococcus suis vaccines to protect against reproductive, nursery-age, and gr2021
Attenuated Pasteurella multocida vaccines and methods of making and use thereof2020
Attenuated Pasteurella multocida vaccines and methods of making and use thereof2020
Attenuated Pasteurella multocida vaccines and methods of making and use thereof2020
Method for porcine circovirus production and PCV2 vaccines2019
Immunological compositions containing attenuated Histophilus somni2018
Immunological compositions containing attenuated Histophilus somni2018
Attenuated Mannheimia haemolytica vaccines and methods of making and use2018
Attenuated Mannheimia haemolytica vaccines and methods of making and use2018
Attenuated Mannheimia haemolytica vaccines and methods of making and use2018